Drug companies like Turing Pharmaceuticals AG and Valeant Pharmaceuticals International Inc., which have significantly raised the prices of their older, off-patent drugs, were accused on Dec. 9 by lawmakers of holding American patients hostage for ransom – a situation some members of Congress argued needs to be controlled through price regulations, like those used to rein in the railroad, electric utilities and telephone industries.
"This is a market failure, and when there's a market failure, the government has a role in addressing it," insisted...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?